Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma - Eggermont, A. et al.
ASCO Annual Meeting Proceedings - Post-Meeting Edition (Volume 29 • Número 18 - Suppl • Junho 2011) PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC) - Paz-Ares, L.G. et al.
Publicado em 26/08/2013.